#BIOSPAIN2023 Interview | "The Administration of LAM561 Shows Promising Results in the Tr... 08/09/2023 Innovative drugs BioSpain We spoke with Cati Ana Rosselló, Head of CMC at Laminar Pharma, a Bronze Sponsor of BIOSPAIN 2023, about the results of... AseBio - Laminar Pharma
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys 07/09/2023 Healthcare Innovative drugs The funds will enable the company to advance the clinical development of its unique, minimally invasive ultrasound-based... Partners - Asabys Partners
The Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park 24/08/2023 Healthcare Innovative drugs Advanced therapies The company specialises in the development of molecules for oncological and gastrointestinal immunological treatments... Partners - Parc Científic de Barcelona
The use of cell secretomes opens a new era of advanced therapies 07/07/2023 Drug discovery Innovative drugs Personalized medicine Advanced therapies The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM) celebrating its 1st... Partners - PEACHES BIOTECH S.L.
WeLab Barcelona and Fundación MEDINA will collaborate to expand the offer of R&D services ... 26/06/2023 Innovative drugs This collaboration allows combining experience and resources for the discovery and development of new therapies. Partners - Fundación Medina
ZIP Solutions and YIMA Announce Strategic Co-Marketing Agreement for Gene Therapy 05/06/2023 Healthcare Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies International ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI-enabled biotech... Partners - Biotechnology Assets
AseBio presents the ‘Map of advanced-therapy capacities of the biotech industry’ in Spain 23/05/2023 Healthcare Innovative drugs Advanced therapies Over 30 innovative biotech companies possess the comprehensive capabilities to develop advanced therapies, from initial... AseBio
AseBio presents the ‘Map of advanced-therapy capacities of the biotech industry’ in Spain 23/05/2023 Over 30 innovative biotech companies possess the comprehensive capabilities to develop advanced therapies, from initial... AseBio
ORYZON to present trial in progress Phase Ib FRIDA study at the upcoming 2023 ASCO annual ... 17/05/2023 Healthcare Innovative drugs Partners - Oryzon Genomics
ORYZON reports financial results and corporate update for quarter ended March 31, 2023 11/05/2023 Healthcare Innovative drugs Personalized medicine ORY-4001, a selective HDAC-6 inhibitor, nominated as clinical development candidate for neurological diseases such as... Partners
